Found: 12
Select item for more details and to access through your institution.
The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 9, p. 1502, doi. 10.1038/leu.2011.112
- By:
- Publication type:
- Article
Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide.
- Published in:
- 2011
- By:
- Publication type:
- Correction notice
Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 3, p. 350, doi. 10.1038/bmt.2010.118
- By:
- Publication type:
- Article
Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma.
- Published in:
- Bone Marrow Transplantation, 2010, v. 45, n. 9, p. 1396, doi. 10.1038/bmt.2009.370
- By:
- Publication type:
- Article
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.
- Published in:
- Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 490, doi. 10.1038/bmt.2009.181
- By:
- Publication type:
- Article
Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma.
- Published in:
- Bone Marrow Transplantation, 2008, v. 41, n. 11, p. 919, doi. 10.1038/bmt.2008.82
- By:
- Publication type:
- Article
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
- Published in:
- 2005
- By:
- Publication type:
- journal article
A phase I study of<sup>153</sup>Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 1, p. 118, doi. 10.1038/sj.leu.2403575
- By:
- Publication type:
- Article
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate.
- Published in:
- Bone Marrow Transplantation, 2004, v. 34, n. 12, p. 1025, doi. 10.1038/sj.bmt.1704691
- By:
- Publication type:
- Article
Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma.
- Published in:
- Bone Marrow Transplantation, 2004, v. 33, n. 3, p. 291, doi. 10.1038/sj.bmt.1704355
- By:
- Publication type:
- Article
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma.
- Published in:
- Bone Marrow Transplantation, 2003, v. 32, n. 3, p. 317, doi. 10.1038/sj.bmt.1704124
- By:
- Publication type:
- Article
Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience.
- Published in:
- Bone Marrow Transplantation, 1998, v. 22, n. 10, p. 981, doi. 10.1038/sj.bmt.1701468
- By:
- Publication type:
- Article